Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Highlights East-African e-Commerce startup Kasha closes a $1M round; Mental Health Femtech startup Clementine raises £1M; Founders Factory New York announced first investments within its Healthcare Program with Strategic Partner Johnson & Johnson Innovation, Presenter…
Swedfund, the Swedish Development finance institution, announced their investment in Kasha Global, a femtech e-commerce platform with subsidiaries in Rwanda and Kenya. Kasha’s platform enables access, education and confidential distribution of women’s contraceptives, menstrual and health products, primarily to underserved women. The company’s innovative multichannel platform supports both offline and online e-commerce, providing customers with the ability to purchase products digitally using…
Fortunis Capital has selected femtech company Clementine for a place in its Top 20 UK Impact Investment fund, starting with an initial investment of £1M. Clementine’s app aims to improve the emotional wellbeing of millions of women all over the world. The London-based impact investor’s £1million funding will accelerate the growth of Clementine. Founded by Kim Palmer, it provides world-leading virtual professional hypnotherapy sessions as well as a suite…
In our Featured Funder Series we regularly introduce you to investors interested in the femtech space. Know someone who should be featured or want to learn about the initiative and previously featured Features Funders? Click here. Today’s featured funders are Linda Greub & Corinne Nevinny, Co-founders & General Partners at Avestria. Tell us a little more about yourself! How did you get into investing? After investing…
In times of COVID-19 in-person events may be cancelled, but that doesn’t stop the femtech community, our #femtechfam, from getting together to network and continue building the future of women’s health. Our events calendar is more busy than ever, and as every month, we want to help you get an overview of the many events and opportunities available. So… Mark your calendar! Oct 28…
McKinsey & Company is hosting the 4th Annual Early Stage Investor Conference (ESIC), the week of December 7th. ESIC 2020 will focus on early stage (seed – series A) bio/medtech, healthtech, fintech sustainability, and – for the first time – femtech ventures for an opportunity to pitch to the investors and others assembled. The December conference will be held virtually and with a global audience. You…
10 pm on yet another mid-pandemic Friday night. I’m at home and my head hurts after a long week. I’m still sitting at my desk. Staring at a bursting inbox as per usual. Procrastinating. Thinking. Pondering. And suddenly realizing that quietly and completely unnoticed Femtech Insider turned 1 a couple of weeks ago. It’s crazy how time flies and even crazier to…
You may have heard that we recently celebrated our first birthday! One year down and many, many more to go! Forgot to get us a gift? No worries: It is not to late! Help us by filling out our first ever Femtech Insider Community Survey below. We’d love to learn more about you, what you like about Femtech Insider and what you’d…
Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Highlights Maternal health startup Oula raises a $3.2M seed round; Babyscripts announces a commercial partnership with Roche; Aavia raised a $3.2M seed round; Natural Cycles adds wearables to its app; Adjuvant Capital announces a $25M investment in Evofem Biosciences (Phexxi),…
October 18, 2020. World Menopause Day aka a couple of *really* busy days for our colleagues innovating for women going through or approaching menopause. Lots of launches, lots of events, lots of press and lots of interest for a condition that affects every single woman on this planet and has been underserved, underresearched and underfunded for far too long. A good sign!…
